Calls for greater healthcare pricing transparency have been gaining steam. A new study in JAMA found use of a private price transparency platform was associated with lower claims payments for 3 common medical services.
Calls for greater healthcare pricing transparency have been gaining steam and recent government and private initiatives have sought to use price transparency to reduce healthcare costs.
A new study in JAMA found that when price transparency information was available for patients to use, total claims payments for common medical services decreased. Researchers studied medical claims from more than half a million patients from 2010 to 2013 to determine whether using an employer-sponsored private price transparency platform was associated with lower claims payments for 3 common medical services.
“Patient access to pricing information before obtaining clinical services may result in lower overall payments made for clinical care,” the authors wrote.
The researchers compared payments between patients who searched a pricing service prior to using a clinical service with patients who had not. The services studied were laboratory tests, advanced imaging services, and clinician office visits.
Once the price transparency platform was available, 5.9% of laboratory test claims, 6.9% of advanced imaging claims, and 26.8% of clinician office visit claims were associated with a prior search.
“It is quite possible that widespread adoption of such solutions by employers will force higher priced providers to reduce their prices,” study author Neeraj Sood, PhD, said in a statement. “The potential savings from such changes in provider behavior could be substantial.”
Overall, patients who searched for services using the platform paid $3.45 less for laboratory tests, $124.74 less for advanced imaging services, and $1.18 less for clinician office visits. Given the relatively small savings for some of the services, the authors wondered what caused patients to change their behavior and conjectured that either some patients recognized that savings per laboratory test could accumulate over time or that less expensive physicians and facilities might actually have been higher quality or simply more convenient.
“The potential for more and lasting behavior change by employees seems truly groundbreaking,” Christopher Whaley, a data scientist at Castlight Health, a PhD candidate at the University of California, Berkeley, and lead author on the JAMA paper said.
Around the Web
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More